Therapy of AIDS-related cryptococcal meningitis

NRH Stone, T Bicanic - Current Treatment Options in Infectious Diseases, 2014 - Springer
Opinion statement Cryptococcal meningitis is a common and severe opportunistic infection
in advanced HIV, with the highest burden of disease in resource-poor settings in sub …

Treatment of HIV-associated cryptococcal meningitis in South Africa: the case for amphotericin B over conventional dose fluconazole for initial therapy: fungal …

JN Jarvis, T Bicanic, TS Harrison - Southern African journal of HIV …, 2007 - journals.co.za
Cryptococcal meningitis is a major cause of morbidity and mortality in African AIDS patients,
accounting for between 13% and 17% of deaths in Ugandan HIV-infected individuals and …

[HTML][HTML] HIV-associated Cryptococcal Meningitis: a review of novel short-course and oral therapies

LR Moeng, J Milburn, JN Jarvis… - Current Treatment Options …, 2020 - Springer
Purpose of review HIV-associated cryptococcal meningitis remains a significant public
health problem in parts of Africa and Asia and a major cause of AIDS-related mortality …

Emerging concepts in HIV-associated cryptococcal meningitis

DS Lawrence, T Boyer-Chammard… - Current opinion in …, 2019 - journals.lww.com
Emerging concepts in HIV-associated cryptococcal meningitis : Current Opinion in Infectious
Diseases Emerging concepts in HIV-associated cryptococcal meningitis : Current Opinion in …

Management of HIV-associated cryptococcal disease in South Africa

NP Govender, S Dlamini - South African medical journal, 2014 - ajol.info
In routine-care settings, the 10-week mortality associated with cryptococcal meningitis (CM)
is high, even with prompt, appropriate antifungal treatment and correctly timed initiation of …

A randomized controlled trial for the treatment of HIV-associated cryptococcal meningitis in Africa: oral fluconazole plus flucytosine or one week amphotericin-based …

S Molloy, C Kanyama, R Heyderman… - Journal of the …, 2017 - openaccess.sgul.ac.uk
Background: Cryptococcal meningitis (CM) accounts for 10–20% of HIV-related deaths and>
100,000 deaths/year. Amphotericin (AmB) plus flucytosine for 2 weeks is considered the …

Cryptococcal meningitis: current approaches to management in patients with and without AIDS

KD Brizendine, PG Pappas - Current infectious disease reports, 2010 - Springer
Cryptococcal meningitis is a life-threatening fungal infection of the central nervous system
(CNS). Its management is characterized by the administration of initial combination …

[HTML][HTML] Antifungal combinations for treatment of cryptococcal meningitis in Africa

SF Molloy, C Kanyama, RS Heyderman… - … England Journal of …, 2018 - Mass Medical Soc
Background Cryptococcal meningitis accounts for more than 100,000 human
immunodeficiency virus (HIV)–related deaths per year. We tested two treatment strategies …

Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for …

A Loyse, D Wilson, G Meintjes, JN Jarvis… - Clinical infectious …, 2012 - academic.oup.com
Abstract (See the Editorial Commentary by Bennett, on pages 129–30.) Background. HIV-
associated cryptococcal meningitis is associated with an estimated 600 000 deaths …

Short‐course amphotericin B in addition to sertraline and fluconazole for treatment of HIV‐associated cryptococcal meningitis in rural Tanzania

A Katende, G Mbwanji, D Faini, A Nyuri… - Mycoses, 2019 - Wiley Online Library
Background Cryptococcal meningitis accounts for 15% of all AIDS mortality globally. Most
cases in low‐and middle‐income countries are treated with fluconazole monotherapy, which …